These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8379466)

  • 21. Immunoglobulin receptors on murine B lymphocytes.
    Vitetta ES; Cambier J; Forman J; Kettman JR; Yuan D; Uhr JW
    Cold Spring Harb Symp Quant Biol; 1977; 41 Pt 1():185-91. PubMed ID: 302188
    [No Abstract]   [Full Text] [Related]  

  • 22. Hapten-specific B lymphocytes: enrichment, cloning, receptor analysis, and tolerance induction.
    Nossal GJ; Pike BL; Stocker JW; Layton JE; Goding JW
    Cold Spring Harb Symp Quant Biol; 1977; 41 Pt 1():237-43. PubMed ID: 408088
    [No Abstract]   [Full Text] [Related]  

  • 23. Difference in apoptosis induction between surface IgD and IgM.
    Peckham D; Andersen-Nissen E; Finkelman FD; Stunz LL; Ashman RF
    Int Immunol; 2001 Mar; 13(3):285-95. PubMed ID: 11222497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signalling in B cells.
    Alés-Martínez JE; Cuende E; Martínez C; Parkhouse RM; Pezzi L; Scott DW
    Immunol Today; 1991 Jun; 12(6):201-5. PubMed ID: 1652257
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of receptor IgM and IgD in determining triggering and induction of tolerance in murine B cells.
    Kettman JR; Cambier JC; Uhr JW; Ligler F; Vitetta ES
    Immunol Rev; 1979; 43():69-95. PubMed ID: 83290
    [No Abstract]   [Full Text] [Related]  

  • 26. IgM-mediated signaling is required for the development of a normal B cell memory response.
    Guo L; Zhang X; Zheng B; Han S
    Mol Immunol; 2008 Feb; 45(4):1071-7. PubMed ID: 17825414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential susceptibility of neonatal and adult murine spleen cells to in vitro induction of B-cell tolerance.
    Cambier JC; Kettman JR; Vitetta ES; Uhr JW
    J Exp Med; 1976 Jul; 144(1):293-7. PubMed ID: 1084409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice.
    Goodnow CC; Crosbie J; Adelstein S; Lavoie TB; Smith-Gill SJ; Brink RA; Pritchard-Briscoe H; Wotherspoon JS; Loblay RH; Raphael K
    Nature; 1988 Aug; 334(6184):676-82. PubMed ID: 3261841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgD can largely substitute for loss of IgM function in B cells.
    Lutz C; Ledermann B; Kosco-Vilbois MH; Ochsenbein AF; Zinkernagel RM; Köhler G; Brombacher F
    Nature; 1998 Jun; 393(6687):797-801. PubMed ID: 9655395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-lymphocyte ontogeny.
    Scher I
    Crit Rev Immunol; 1981 Feb; 1(4):287-320. PubMed ID: 6800696
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunoglobulin-receptors revisited.
    Vitetta ES; Uhr JW
    Science; 1975 Sep; 189(4207):964-9. PubMed ID: 1083069
    [No Abstract]   [Full Text] [Related]  

  • 32. IgD as a receptor in signaling the proliferation of mouse B-lymphocytes.
    Sieckmann DG; Finkelman FD; Scher I
    Ann N Y Acad Sci; 1982; 399():277-89. PubMed ID: 6984610
    [No Abstract]   [Full Text] [Related]  

  • 33. B-cell function in mice treated with anti-IgD from birth.
    Metcalf ES; Mond JJ; Scher I; LaVeck MA; Finkelman FD
    Ann N Y Acad Sci; 1982; 399():351-9. PubMed ID: 6984618
    [No Abstract]   [Full Text] [Related]  

  • 34. Multiple pathways of B lymphocyte tolerance.
    Scott DW; Venkataraman M; Jandinski JJ
    Immunol Rev; 1979; 43():241-80. PubMed ID: 365712
    [No Abstract]   [Full Text] [Related]  

  • 35. Current problem areas in the study of B lymphocyte differentiation.
    Nossal GJ; Shortman K; Howard M; Pike BL
    Immunol Rev; 1977; 37():187-209. PubMed ID: 338465
    [No Abstract]   [Full Text] [Related]  

  • 36. Antigen receptor-triggered apoptosis in immature B cell lines is associated with the binding of a 44-kDa phosphoprotein to the PTP1C tyrosine phosphatase.
    Wu Y; Pani G; Siminovitch K; Hozumi N
    Eur J Immunol; 1995 Aug; 25(8):2279-84. PubMed ID: 7664792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu.
    Scott DW; Livnat D; Pennell CA; Keng P
    J Exp Med; 1986 Jul; 164(1):156-64. PubMed ID: 3487612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of B-cell tolerance.
    Jacquemin MG; Vanzieleghem B; Saint-Remy JM
    Adv Exp Med Biol; 2001; 489():99-108. PubMed ID: 11554595
    [No Abstract]   [Full Text] [Related]  

  • 39. Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection.
    Melamed D; Benschop RJ; Cambier JC; Nemazee D
    Cell; 1998 Jan; 92(2):173-82. PubMed ID: 9458042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B cell expression of the SH2-containing inositol 5-phosphatase (SHIP-1) is required to establish anergy to high affinity, proteinacious autoantigens.
    Akerlund J; Getahun A; Cambier JC
    J Autoimmun; 2015 Aug; 62():45-54. PubMed ID: 26152931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.